APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fludeoxyglucose F 18 Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fludeoxyglucose F 18 Injection Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchFludeoxyglucose F 18 Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Fludeoxyglucose F 18 Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Fludeoxyglucose F 18 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fludeoxyglucose F 18 Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Fludeoxyglucose F 18 Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Fludeoxyglucose F 18 Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fludeoxyglucose F 18 Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fludeoxyglucose F 18 Injection market include China Isotope & Radiation Corporation, Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Shanghai Atom Kexing Pharmaceutical Co.,Ltd., HUAYI Technology, Guangdong Cyclotron Medical Science Co., Ltd, Siemens(PETNet) and Isologic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fludeoxyglucose F 18 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fludeoxyglucose F 18 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fludeoxyglucose F 18 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fludeoxyglucose F 18 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Fludeoxyglucose F 18 Injection Segment by Company

China Isotope & Radiation Corporation

Hta Co., Ltd

Yantai Dongcheng Biochemicals Co.,Ltd.

Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

HUAYI Technology

Guangdong Cyclotron Medical Science Co., Ltd

Siemens(PETNet)

Isologic

Fludeoxyglucose F 18 Injection Segment by Type

＜200 mCi/1mL

＞300 mCi/1mL

200-300 mCi/1mL

Fludeoxyglucose F 18 Injection Segment by Application

Heart Disease

Epilepsy

Cancer

Fludeoxyglucose F 18 Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fludeoxyglucose F 18 Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fludeoxyglucose F 18 Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fludeoxyglucose F 18 Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Fludeoxyglucose F 18 Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fludeoxyglucose F 18 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fludeoxyglucose F 18 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fludeoxyglucose F 18 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fludeoxyglucose F 18 Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fludeoxyglucose F 18 Injection industry.

Chapter 3: Detailed analysis of Fludeoxyglucose F 18 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fludeoxyglucose F 18 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fludeoxyglucose F 18 Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fludeoxyglucose F 18 Injection Industry Trends Table 2. Fludeoxyglucose F 18 Injection Industry Drivers Table 3. Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges Table 4. Fludeoxyglucose F 18 Injection Industry Restraints Table 5. Global Fludeoxyglucose F 18 Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fludeoxyglucose F 18 Injection Revenue Share by Company (2021-2026) Table 7. Global Fludeoxyglucose F 18 Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Company (2021-2026) Table 9. Global Fludeoxyglucose F 18 Injection Average Price (US$/unit) of Company (2021-2026) Table 10. Global Fludeoxyglucose F 18 Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fludeoxyglucose F 18 Injection Key Company Manufacturing Base & Headquarters Table 12. Global Fludeoxyglucose F 18 Injection Company, Product Type & Application Table 13. Global Fludeoxyglucose F 18 Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fludeoxyglucose F 18 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ＜200 mCi/1mL Table 18. Significant Companies of ＞300 mCi/1mL Table 19. Significant Companies of 200-300 mCi/1mL Table 20. Global Fludeoxyglucose F 18 Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Fludeoxyglucose F 18 Injection Sales Volume by Type (2021-2026) & (k units) Table 22. Global Fludeoxyglucose F 18 Injection Sales Volume by Type (2027-2032) & (k units) Table 23. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Type (2021-2026) Table 24. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Type (2027-2032) Table 25. Global Fludeoxyglucose F 18 Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fludeoxyglucose F 18 Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Fludeoxyglucose F 18 Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Fludeoxyglucose F 18 Injection Sales Value Share by Type (2021-2026) Table 29. Global Fludeoxyglucose F 18 Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Heart Disease Table 31. Significant Companies of Epilepsy Table 32. Significant Companies of Cancer Table 33. Global Fludeoxyglucose F 18 Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Fludeoxyglucose F 18 Injection Sales Volume by Application (2021-2026) & (k units) Table 35. Global Fludeoxyglucose F 18 Injection Sales Volume by Application (2027-2032) & (k units) Table 36. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Application (2021-2026) Table 37. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Application (2027-2032) Table 38. Global Fludeoxyglucose F 18 Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Fludeoxyglucose F 18 Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Fludeoxyglucose F 18 Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Fludeoxyglucose F 18 Injection Sales Value Share by Application (2021-2026) Table 42. Global Fludeoxyglucose F 18 Injection Sales Value Share by Application (2027-2032) Table 43. Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2026) & (k units) Table 45. Global Fludeoxyglucose F 18 Injection Sales Market Share by Region (2021-2026) Table 46. Global Fludeoxyglucose F 18 Injection Sales by Region (2027-2032) & (k units) Table 47. Global Fludeoxyglucose F 18 Injection Sales Market Share by Region (2027-2032) Table 48. Global Fludeoxyglucose F 18 Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Fludeoxyglucose F 18 Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Fludeoxyglucose F 18 Injection Sales Value Share by Region (2021-2026) Table 51. Global Fludeoxyglucose F 18 Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Fludeoxyglucose F 18 Injection Sales Value Share by Region (2027-2032) Table 53. Global Fludeoxyglucose F 18 Injection Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Fludeoxyglucose F 18 Injection Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Fludeoxyglucose F 18 Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Fludeoxyglucose F 18 Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Fludeoxyglucose F 18 Injection Sales by Country (2021-2026) & (k units) Table 58. Global Fludeoxyglucose F 18 Injection Sales Market Share by Country (2021-2026) Table 59. Global Fludeoxyglucose F 18 Injection Sales by Country (2027-2032) & (k units) Table 60. Global Fludeoxyglucose F 18 Injection Sales Market Share by Country (2027-2032) Table 61. Global Fludeoxyglucose F 18 Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Fludeoxyglucose F 18 Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Fludeoxyglucose F 18 Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Fludeoxyglucose F 18 Injection Sales Value Market Share by Country (2027-2032) Table 65. China Isotope & Radiation Corporation Company Information Table 66. China Isotope & Radiation Corporation Business Overview Table 67. China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio Table 69. China Isotope & Radiation Corporation Recent Development Table 70. Hta Co., Ltd Company Information Table 71. Hta Co., Ltd Business Overview Table 72. Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio Table 74. Hta Co., Ltd Recent Development Table 75. Yantai Dongcheng Biochemicals Co.,Ltd. Company Information Table 76. Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview Table 77. Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio Table 79. Yantai Dongcheng Biochemicals Co.,Ltd. Recent Development Table 80. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information Table 81. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview Table 82. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio Table 84. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Development Table 85. HUAYI Technology Company Information Table 86. HUAYI Technology Business Overview Table 87. HUAYI Technology Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio Table 89. HUAYI Technology Recent Development Table 90. Guangdong Cyclotron Medical Science Co., Ltd Company Information Table 91. Guangdong Cyclotron Medical Science Co., Ltd Business Overview Table 92. Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio Table 94. Guangdong Cyclotron Medical Science Co., Ltd Recent Development Table 95. Siemens(PETNet) Company Information Table 96. Siemens(PETNet) Business Overview Table 97. Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio Table 99. Siemens(PETNet) Recent Development Table 100. Isologic Company Information Table 101. Isologic Business Overview Table 102. Isologic Fludeoxyglucose F 18 Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Isologic Fludeoxyglucose F 18 Injection Product Portfolio Table 104. Isologic Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Fludeoxyglucose F 18 Injection Distributors List Table 108. Fludeoxyglucose F 18 Injection Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Fludeoxyglucose F 18 Injection Product Image Figure 2. Global Fludeoxyglucose F 18 Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fludeoxyglucose F 18 Injection Sales (2021-2032) & (k units) Figure 5. Global Fludeoxyglucose F 18 Injection Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Fludeoxyglucose F 18 Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ＜200 mCi/1mL Image Figure 10. ＞300 mCi/1mL Image Figure 11. 200-300 mCi/1mL Image Figure 12. Global Fludeoxyglucose F 18 Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Fludeoxyglucose F 18 Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Fludeoxyglucose F 18 Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Fludeoxyglucose F 18 Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Fludeoxyglucose F 18 Injection Sales Value Share by Type (2021-2032) Figure 18. Heart Disease Image Figure 19. Epilepsy Image Figure 20. Cancer Image Figure 21. Global Fludeoxyglucose F 18 Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Fludeoxyglucose F 18 Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Fludeoxyglucose F 18 Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Fludeoxyglucose F 18 Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Fludeoxyglucose F 18 Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Fludeoxyglucose F 18 Injection Sales Value Share by Application (2021-2032) Figure 27. Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Fludeoxyglucose F 18 Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Fludeoxyglucose F 18 Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Fludeoxyglucose F 18 Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Fludeoxyglucose F 18 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Fludeoxyglucose F 18 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Fludeoxyglucose F 18 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Fludeoxyglucose F 18 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Fludeoxyglucose F 18 Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Fludeoxyglucose F 18 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Fludeoxyglucose F 18 Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Fludeoxyglucose F 18 Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • ＜200 mCi/1mL
  • ＞300 mCi/1mL
  • 200-300 mCi/1mL
Applications
  • Heart Disease
  • Epilepsy
  • Cancer
Companies covered
  • China Isotope & Radiation Corporation
  • Hta Co., Ltd
  • Yantai Dongcheng Biochemicals Co.,Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
  • HUAYI Technology
  • Guangdong Cyclotron Medical Science Co., Ltd
  • Siemens(PETNet)
  • Isologic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  4. 1.2.2 Global Fludeoxyglucose F 18 Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Fludeoxyglucose F 18 Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fludeoxyglucose F 18 Injection Market Dynamics
  1. 2.1 Fludeoxyglucose F 18 Injection Industry Trends
  2. 2.2 Fludeoxyglucose F 18 Injection Industry Drivers
  3. 2.3 Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges
  4. 2.4 Fludeoxyglucose F 18 Injection Industry Restraints
3 Fludeoxyglucose F 18 Injection Market by Company
  1. 3.1 Global Fludeoxyglucose F 18 Injection Company Revenue Ranking in 2025
  2. 3.2 Global Fludeoxyglucose F 18 Injection Revenue by Company (2021-2026)
  3. 3.3 Global Fludeoxyglucose F 18 Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Fludeoxyglucose F 18 Injection Average Price by Company (2021-2026)
  5. 3.5 Global Fludeoxyglucose F 18 Injection Company Ranking (2024-2026)
  6. 3.6 Global Fludeoxyglucose F 18 Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Fludeoxyglucose F 18 Injection Company Product Type and Application
  8. 3.8 Global Fludeoxyglucose F 18 Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fludeoxyglucose F 18 Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fludeoxyglucose F 18 Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fludeoxyglucose F 18 Injection Market by Type
  1. 4.1 Fludeoxyglucose F 18 Injection Type Introduction
  2. 4.1.1 ＜200 mCi/1mL
  3. 4.1.2 ＞300 mCi/1mL
  4. 4.1.3 200-300 mCi/1mL
  5. 4.2 Global Fludeoxyglucose F 18 Injection Sales Volume by Type
  6. 4.2.1 Global Fludeoxyglucose F 18 Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fludeoxyglucose F 18 Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Fludeoxyglucose F 18 Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Fludeoxyglucose F 18 Injection Sales Value by Type
  10. 4.3.1 Global Fludeoxyglucose F 18 Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Fludeoxyglucose F 18 Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Fludeoxyglucose F 18 Injection Sales Value Share by Type (2021-2032)
5 Fludeoxyglucose F 18 Injection Market by Application
  1. 5.1 Fludeoxyglucose F 18 Injection Application Introduction
  2. 5.1.1 Heart Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Cancer
  5. 5.2 Global Fludeoxyglucose F 18 Injection Sales Volume by Application
  6. 5.2.1 Global Fludeoxyglucose F 18 Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fludeoxyglucose F 18 Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Fludeoxyglucose F 18 Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Fludeoxyglucose F 18 Injection Sales Value by Application
  10. 5.3.1 Global Fludeoxyglucose F 18 Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fludeoxyglucose F 18 Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Fludeoxyglucose F 18 Injection Sales Value Share by Application (2021-2032)
6 Fludeoxyglucose F 18 Injection Regional Sales and Value Analysis
  1. 6.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Fludeoxyglucose F 18 Injection Sales by Region (2027-2032)
  5. 6.3 Global Fludeoxyglucose F 18 Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fludeoxyglucose F 18 Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fludeoxyglucose F 18 Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fludeoxyglucose F 18 Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Fludeoxyglucose F 18 Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  12. 6.6.2 North America Fludeoxyglucose F 18 Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Fludeoxyglucose F 18 Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fludeoxyglucose F 18 Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  21. 6.9.2 South America Fludeoxyglucose F 18 Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fludeoxyglucose F 18 Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fludeoxyglucose F 18 Injection Sales Value Share by Country, 2025 VS 2032
7 Fludeoxyglucose F 18 Injection Country-level Sales and Value Analysis
  1. 7.1 Global Fludeoxyglucose F 18 Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fludeoxyglucose F 18 Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Fludeoxyglucose F 18 Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Fludeoxyglucose F 18 Injection Sales by Country (2027-2032)
  6. 7.4 Global Fludeoxyglucose F 18 Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fludeoxyglucose F 18 Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fludeoxyglucose F 18 Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fludeoxyglucose F 18 Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fludeoxyglucose F 18 Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fludeoxyglucose F 18 Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Isotope & Radiation Corporation
  2. 8.1.1 China Isotope & Radiation Corporation Company Information
  3. 8.1.2 China Isotope & Radiation Corporation Business Overview
  4. 8.1.3 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio
  6. 8.1.5 China Isotope & Radiation Corporation Recent Developments
  7. 8.2 Hta Co., Ltd
  8. 8.2.1 Hta Co., Ltd Company Information
  9. 8.2.2 Hta Co., Ltd Business Overview
  10. 8.2.3 Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
  12. 8.2.5 Hta Co., Ltd Recent Developments
  13. 8.3 Yantai Dongcheng Biochemicals Co.,Ltd.
  14. 8.3.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
  15. 8.3.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
  16. 8.3.3 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
  18. 8.3.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
  19. 8.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
  20. 8.4.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
  21. 8.4.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview
  22. 8.4.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
  24. 8.4.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
  25. 8.5 HUAYI Technology
  26. 8.5.1 HUAYI Technology Company Information
  27. 8.5.2 HUAYI Technology Business Overview
  28. 8.5.3 HUAYI Technology Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio
  30. 8.5.5 HUAYI Technology Recent Developments
  31. 8.6 Guangdong Cyclotron Medical Science Co., Ltd
  32. 8.6.1 Guangdong Cyclotron Medical Science Co., Ltd Company Information
  33. 8.6.2 Guangdong Cyclotron Medical Science Co., Ltd Business Overview
  34. 8.6.3 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
  36. 8.6.5 Guangdong Cyclotron Medical Science Co., Ltd Recent Developments
  37. 8.7 Siemens(PETNet)
  38. 8.7.1 Siemens(PETNet) Company Information
  39. 8.7.2 Siemens(PETNet) Business Overview
  40. 8.7.3 Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio
  42. 8.7.5 Siemens(PETNet) Recent Developments
  43. 8.8 Isologic
  44. 8.8.1 Isologic Company Information
  45. 8.8.2 Isologic Business Overview
  46. 8.8.3 Isologic Fludeoxyglucose F 18 Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Isologic Fludeoxyglucose F 18 Injection Product Portfolio
  48. 8.8.5 Isologic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fludeoxyglucose F 18 Injection Value Chain Analysis
  2. 9.1.1 Fludeoxyglucose F 18 Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fludeoxyglucose F 18 Injection Sales Mode & Process
  6. 9.2 Fludeoxyglucose F 18 Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fludeoxyglucose F 18 Injection Distributors
  9. 9.2.3 Fludeoxyglucose F 18 Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst